Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 20/20 | 0.84 |
| ▸ | KCNH2 | Q12809 | 18/20 | 0.80 |
| ▸ | MCHR2 | Q969V1 | 10/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6329386 | 0.93 | MCHR1 (0.81) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6339148 | 0.88 | MCHR1 (0.82) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6336230 | 0.88 | MCHR1 (0.88) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6337379 | 0.88 | MCHR1 (0.89) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6337375 | 0.87 | MCHR1 (0.81) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6333889 | 0.87 | MCHR1 (1.00) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6333436 | 0.87 | MCHR1 (0.87) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6338999 | 0.87 | MCHR1 (0.87) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL6336236 | 0.86 | MCHR1 (0.80) | MCHR1KCNH2MCHR2CYP3A4 | |
| SCHEMBL2669492 | 0.86 | MCHR1 (1.00) | MCHR1KCNH2MCHR2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2024347-B1 | PHENYLAMINO-BENZOXAZOLE SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THEIR PRODUCTION AND USE THEREOF AS MEDICAMENTS | SANOFI SA (FR) | 2012-08-01 | — | — | EP | disclosed |
| EP-2024340-B1 | 4,5-DIPHENYL-PYRIMIDINYL-AMINO SUBSTITUTED CARBOXYLIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS | SANOFI SA (FR) | 2012-07-18 | — | — | EP | disclosed |
| EP-2310372-B1 | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof | SANOFI SA (FR) | 2012-05-23 | — | — | EP | disclosed |
| EP-2240474-B1 | CYCLIC PYRIDYL-N-(1,3,4)-THIADIAZOL-2-YL-BENZENE SULFONAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2012-03-14 | — | — | EP | disclosed |
| EP-1934206-B1 | PHENYL- AND PYRIDYL-I, 2 , 4 -OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2011-12-14 | — | — | EP | disclosed |
| EP-2001878-B1 | IMIDAZOPYRIDIN-2-ONE DERIVATIVES AS INHIBITORS OF ENDOTHELIAL LIPASE | SANOFI SA (FR) | 2011-10-12 | — | — | EP | disclosed |
| EP-2183222-B1 | AZOLORAINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, AND THE USE THEREOF | SANOFI SA (FR) | 2011-08-03 | — | — | EP | disclosed |
| EP-2203448-B1 | PHENOTHIAZINE DERIVATIVE HAVING A DOUBLE BOND, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A PHARMACEUTICAL | SANOFI AVENTIS (FR) | 2011-06-22 | — | — | EP | disclosed |
| EP-2084173-B1 | NOVEL 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH FLUORINE, METHOD FOR PRODUCING THE SAME, DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-12-29 | — | — | EP | disclosed |
| EP-2084172-B1 | NOVEL 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-12-22 | — | — | EP | disclosed |
| EP-2152711-B1 | 2 -HETEROARYL- PYRROLO [3, 4-C]PYRROLE DERIVATIVES AND THEIR USE AS SCD INHIBITORS | SANOFI AVENTIS (FR) | 2010-11-24 | — | — | EP | disclosed |
| EP-2084143-B1 | NOVEL 1,4-BENZOTHIEPIN-1,1 -DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH CYCLOHEXYL GROUPS, METHOD FOR PRODUCING THE SAME, DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-01-27 | — | — | EP | disclosed |